All Stories

  1. Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease

    Article • Cardiovascular & Hematological Agents in Medicinal Chemistry, September 2018, Bentham Science Publishers

    Dr Amit Arvind Joharapurkar

  2. Recent Developments in HIF Prolyl Hydroxylase Inhibitors

    Article • October 2015, American Chemical Society (ACS)

    Dr Amit Arvind Joharapurkar

  3. Central GLP-1 receptor activation improves cholesterol metabolism partially independent of its effect on food intake

    Article • Canadian Journal of Physiology and Pharmacology, July 2015, Canadian Science Publishing

    Dr Amit Arvind Joharapurkar

  4. Therapeutic Potential of Coagonists of Glucagon and GLP-1

    Article • Cardiovascular & Hematological Agents in Medicinal Chemistry, January 2015, Bentham Science Publishers

    Dr Amit Arvind Joharapurkar

  5. Effect of GLP-1 Based Therapies on Diabetic Dyslipidemia

    Article • Current Diabetes Reviews, July 2014, Bentham Science Publishers

    Dr Amit Arvind Joharapurkar

  6. Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity

    Article • Diabetes Metabolic Syndrome and Obesity, February 2014, Taylor & Francis

    Dr Amit Arvind Joharapurkar

  7. Thyroid Hormone Modulates Food Intake and Glycemia via Ghrelin Secretion in Zucker Fatty rats

    Article • Drug Research, December 2013, Thieme Publishing Group

    Dr Amit Arvind Joharapurkar

  8. Peptidomimetics as Potent and Selective PTP1B Inhibitors

    Article • Medicinal Chemistry, June 2013, Bentham Science Publishers

    Dr Amit Arvind Joharapurkar

  9. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase

    Article • Journal of Diabetes, November 2012, Wiley

    Dr Amit Arvind Joharapurkar

  10. 11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome

    Article • Pharmacological Reports, September 2012, Elsevier

    Dr Amit Arvind Joharapurkar

  11. Selective Thyromimetics Using Receptor and Tissue Selectivity Approaches: Prospects for Dyslipidemia

    Article • Journal of Medicinal Chemistry, May 2012, American Chemical Society (ACS)

    Dr Amit Arvind Joharapurkar

  12. Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect

    Article • Pharmacological Reports, January 2012, Elsevier

    Dr Amit Arvind Joharapurkar

  13. Antinociceptive activity of alcoholic extract of Hemidesmus indicus R.Br. in mice

    Article • Journal of Ethnopharmacology, November 2005, Elsevier

    Dr Amit Arvind Joharapurkar